Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes.

Autor: Zhang, Xianyu1 (AUTHOR), Jiang, Jian1 (AUTHOR), Xu, Jiajia1 (AUTHOR), Chen, Jian1 (AUTHOR), Gu, Yuntao2 (AUTHOR) 18608956606@163.com, Wu, Guobao1 (AUTHOR) wu900808@126.com
Zdroj: BMC Musculoskeletal Disorders. 7/30/2024, Vol. 25 Issue 1, p1-11. 11p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje